Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 25 Nov 2025 for Olema Pharmaceuticals, Inc., €12k. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Andrew Rappaport: trading record in brief
Andrew Rappaport appears in our data through filings on Olema Pharmaceuticals, Inc. shares, published by SEC (Form 4). Between 5 March 2024 and 21 November 2025, the trades on record add up to 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 25 November 2025: an option exercise of €12k, in Olema Pharmaceuticals, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Andrew Rappaport
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
35,868 shares@ US$0.39100.0% of flowCommon StockSEC:0001162157-25-000005:0
481,014 shares0Common StockSEC:0001415889-24-007081:0
2 of 2 declarations
